Mouse model as an efficacy test for foot‐and‐mouth disease vaccines
Protection against foot‐and‐mouth disease virus (FMDV) has been linked to the development of a humoral response. In Argentina, the official control tests for assessing the potency of FMD vaccines are protection against podal generalization (PPG) and expected percentage of protection (EPP) curves bui...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Wiley
2020
|
| Materias: | |
| Acceso en línea: | http://hdl.handle.net/20.500.12123/7741 https://onlinelibrary.wiley.com/doi/abs/10.1111/tbed.13591 https://doi.org/10.1111/tbed.13591 |
Ejemplares similares: Mouse model as an efficacy test for foot‐and‐mouth disease vaccines
- Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity
- A new cage-like particle adjuvant enhances protection of foot-and-mouth disease vaccine
- Advances in novel vaccines for foot and mouth disease: focus on recombinant empty capsids
- Differential replication of Foot-and-mouth disease viruses in mice determine lethality
- Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant
- FMD empty capsids combined with the immunostant particle adjuvant -ISPA or ISA206 induce protective immunity against foot and mouth disease virus